Asia Pacific Single-use Bioprocessing Systems Market: Snapshot
The market for single-use bioprocessing systems in Asia Pacific has witnessed an impressive rise since its inception and is expected to remain growing significantly, thanks to the rising adoption of single-use technology among small biotechnology startups and biopharmaceutical enterprises. As the biopharmaceutical industry is maturing, organizations across Asia Pacific are progressively focusing on finding innovative treatment solutions, which are not only different from their competitors, but also have a reduced pipeline for development that helps in bringing the product faster to the market.
Since single-use bioprocessing systems allow biopharmaceutical organizations to speed-up the research and development activities and scale up the process from pilot level to production level for the manufacturing of biopharmaceuticals, with the added advantage of reduced investment and production costs, their popularity has substantially increased, which is reflecting on their demand. The rising usage of single-use bioprocess systems at the manufacturing stage in the cGMP production of biologics is likely to boost this market over the forthcoming years.
The Asia Pacific market for single-use bioprocessing systems, which stood at US$495.0 mn in 2015, is expected to increase at a CAGR of 12.50% between 2016 and 2024 and touch a value of US$1,417.2 mn by the end of 2024.
Demand for Single-use Bags to Remain Strong
Single-use bioreactors, mixers, bags, tubing, bioprocess containers, filtration devices, sampling systems, connectors and clamps, and probes and sensors are the key products available in the Asia Pacific market for single-use bioprocessing systems. The demand for single-use bags is higher than other products in this market. Due to the higher rate of product adoption in research labs and pilot scale bioprocessing plants, supported by their cost effectiveness, this segment is likely to remain witnessing strong growth over the next few years. Single-use bioreactors are also expected to witness healthy growth in their demand in the near future.
Vaccine production, biosimilar, blood plasma products, cell therapy, and several other bio pharma products have emerged as the key application areas of single-use bioprocessing systems. Vaccine production segment has been reporting the most prominent demand for these systems. Researchers expect this scenario to continue like this in the near future, thanks to the acceleration in the fields of drug discovery and the increasing prevalence of chronic diseases in Asia Pacific.
China to Continue Leading Asia Pacific Single-use Bioprocessing Systems Market
Geographically, the Asia Pacific market for single-use bioprocessing systems has spread across China, Japan, India, South Korea, Taiwan, Australia and New Zealand, South East Asian countries and the Rest of Asia Pacific. In 2015, China led the overall market with a share of 33.0% on the grounds of new product launches. Over the forthcoming years, the domestic market is likely to remain on the top, thanks to the presence of a large pool of players.
Japan stood second in the Asia Pacific market for single-use bioprocessing systems in 2015. Expanding at an exponential growth rate compared to other domestic markets, it is likely to witness a high rise in its market share. The increasing demand for cost effective and prefabricated modular bioprocessing facilities, introduction of new products, and the expansion in the pharmaceutical and biotechnology industry are expected to boost the Japan single-use bioprocessing systems market in the years to come.
At the forefront of the Asia Pacific market for single-use bioprocessing systems are Danaher Corp., Eppendorf AG, Finesse Solutions, GE Healthcare, Colder Products Co., Merck KgaA, Parker Hannifin Corp., CESCO Bioengineering Co. Ltd., Saint-Gobain, Sartorius AG, Corning Inc., Thermo Fisher Scientific Inc., and Cole - Parmer Instrument Co. LLC.
Asia Pacific Single-use Bioprocessing System Market: Overview
This report on single-use bioprocessing systems market studies the current as well as future prospects of the market in Asia Pacific. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various single-use bioprocessing systems instrument and products as well as new entrants planning to enter this market.
This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments considered within the scope of the study. This section also provides the overall information and data analysis of the Asia Pacific single-use bioprocessing systems market with respect to the leading market segments based on major products, applications, end-users and geographies.
The market overview section of the report explores the market dynamics such as drivers, restraints, and opportunities that currently have a strong impact on the Asia Pacific single-use bioprocessing systems market and could influence the market in the near future. Market attractiveness analysis has been provided in all the sections of the report in order to explain the intensity of competition in the market across different products/materials/technologies/end-users/geographies.
Asia Pacific Single-use Bioprocessing System Market: Segmentation
The Asia Pacific single-use bioprocessing systems market is divided into: by product, by technology, by application, by end-user and by geography. Product type segment of single-use bioprocessing system market was divided into bioreactors, mixers, bags, bioprocess containers, filtration devices, tubing, sampling systems, connectors & clamps, probes & sensors. On the basis of application the single-use bioprocessing systems market is classified as vaccine production, biosimilar Production, blood plasma products, cell therapy, and other biopharma products. On the basis of end-user the single-use bioprocessing systems market is classified as pharmaceutical, biotechnology, CRO & CMO, and academic & research institutes.
Geographically, the single-use bioprocessing systems market has been segmented into six countries and two regions: China, Japan, Australia & New Zealand, India, South Korea, Taiwan, South East Asian countries and Rest of APAC. Each regional market for single-use bioprocessing systems market has been further categorized into major product, applications, material, and end-user segments considered within the scope of the study. Major country market revenues have also been provided in different regional sections within the report. Market revenue in terms of US$ Mn and volume in terms of units for the period from 2014 to 2025 along with CAGR % from 2016 to 2025 are provided for all the regions and nations considering 2016 as the base year.
The market for these segments has been extensively analyzed based on their utility, effectiveness, sales, and geographic presence. Market revenue in terms of US$ Mn and market volume in terms of units for the period from 2016 to 2024 along with the compound annual growth rate (CAGR %) from 2016 to 2024 are provided for all segments, considering 2016 as the base year.
Asia Pacific Single-use Bioprocessing System Market: Competitive Analysis
The competitive scenario among different market players is evaluated through market share analysis in the competition landscape section of the report. The section also includes completion matrix that analyzes the competition among some of the top Asia Pacific players operating in the market. All these factors would help market players to take strategic decisions in order to strengthen their positions and expand their shares in the Asia Pacific market.
The report profiles key manufacturers in the single-use bioprocessing systems market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include Thermo Fisher Scientific, Merck KGaA (Merck Millipore), Danaher Corporation (Pall Corporation), Sartorius AG, Eppendorf AG, GE Healthcare, Finesse Solutions, Saint-Gobain, Parker Hannifin Corporation, Corning Incorporated, Colder Products Company, CESCO BIOENGINEERING CO., LTD., and Cole-Parmer Instrument Company, LLC.
The Asia Pacific single-use bioprocessing systems market has been segmented as follows:
- Bioprocess Containers
- Filtration Devices
- Sampling Systems
- Connectors & Clamps
- Probes & Sensors
By End User
- CRO & CMO
- Academic & Research Institutes
- Vaccine Production
- Biosimilar Production
- Blood Plasma Products
- Cell Therapy
- Others (biopharma products)
- Australia & New Zealand
- South Korea
- South East Asian countries
- Rest of APAC